Eyenovia Inc (EYEN) concluded trading on Thursday at a closing price of $1.44, with 8.77 million shares of worth about $12.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -96.46% during that period and on March 20, 2025 the price saw a loss of about -13.77%. Currently the company’s common shares owned by public are about 2.10M shares, out of which, 2.08M shares are available for trading.
Stock saw a price change of -11.11% in past 5 days and over the past one month there was a price change of -20.88%. Year-to-date (YTD), EYEN shares are showing a performance of -87.67% which decreased to -98.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.43 but also hit the highest price of $124.80 during that period. The average intraday trading volume for Eyenovia Inc shares is 326.67K. The stock is currently trading -11.11% below its 20-day simple moving average (SMA20), while that difference is down -53.70% for SMA50 and it goes to -95.82% lower than SMA200.
Eyenovia Inc (NASDAQ: EYEN) currently have 2.10M outstanding shares and institutions hold larger chunk of about 3.35% of that.
The stock has a current market capitalization of $3.02M and its 3Y-monthly beta is at 1.04. It has posted earnings per share of -$58.50 in the same period. It has Quick Ratio of 0.53 while making debt-to-equity ratio of 3.51. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EYEN, volatility over the week remained 7.32% while standing at 9.65% over the month.
Stock’s fiscal year EPS is expected to rise by 98.83% while it is estimated to decrease by -2504.84% in next year. EPS is likely to grow at an annualized rate of 35.15% for next 5-years, compared to annual growth of 18.26% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on November 18, 2024 offering a Neutral rating for the stock and assigned a target price range of between $12 and $2 to it. Coverage by Northland Capital stated Eyenovia Inc (EYEN) stock as an Outperform in their note to investors on March 01, 2021, suggesting a price target of $10 for the stock.
